Endo International plc 13D and 13G filings for BIOSPECIFICS TECHNOLOGIES CORP:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-12-03 8:26 pm Sale | 2020-12-02 | 13D | BIOSPECIFICS TECHNOLOGIES CORP BSTC | Endo International plc ENDP | 100 100.000% | -934,973 (-99.99%) | Filing |
| 2020-10-29 5:24 pm Purchase | 2020-10-19 | 13D | BIOSPECIFICS TECHNOLOGIES CORP BSTC | Endo International plc ENDP | 935,073 12.700% | 935,073 (New Position) | Filing |